The Life Raft Group had the pleasure of hosting the global New Horizons GIST meeting this year in our Wayne, New Jersey office. This international meeting traditionally gathers global GIST advocates with the shared [...]
Miami GDOLOn Saturday, March 25th, The Life Raft Group held the first 2017 GIST Day of Learning, also known as “GDOL,” in Miami, Florida. GDOLs are free, one-day programs that provide both education and support [...]
The LRG 2016 GIST Days of Learning Tour (GDOL) made a stop in New York City on June 29th. A GIST Day of Learning is a free, one-day program that provides both education and support [...]
Dr. Alexander Drilon of Memorial Sloan Kettering Cancer Center recently reported at AACR on a potential new cancer treatment, Entrectinib, a receptor tyrosine kinase (RTK) inhibitor developed to target tumors carrying NTRK1, NTRK2, NTRK3, ROS1, [...]
Memorial Sloan Kettering Cancer Center (MSKCC) recently announced results from a "basket study," an innovative clinical trial design that studies response to drugs based on specific mutations in patients' tumors rather than where the cancer originated. [...]
The GIST Group of Switzerland awarded its science prize for the third time on November 22, 2012. It has been awarded ex aequo to Dr. Daniel Perez, Memorial Sloan-Kettering Cancer Center (MSKCC), New York, USA, and Dr. Michael Montemurro, CHUV Lausanne/University Hospital Zurich.